Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CX-024414 Cause Therapeutic response shortened? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Therapeutic response shortened have been filed in association with CX-024414. This represents 0.9% of all adverse event reports for CX-024414.

6
Reports of Therapeutic response shortened with CX-024414
0.9%
of all CX-024414 reports
0
Deaths
3
Hospitalizations

How Dangerous Is Therapeutic response shortened From CX-024414?

Of the 6 reports, 3 (50.0%) required hospitalization.

Is Therapeutic response shortened Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CX-024414. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does CX-024414 Cause?

Fatigue (117) Pyrexia (89) Headache (87) Pain (81) Nausea (69) Chills (64) Pain in extremity (59) Arthralgia (49) Diarrhoea (45) Malaise (40)

What Other Drugs Cause Therapeutic response shortened?

DUPILUMAB (6,720) ADALIMUMAB (2,597) INFLIXIMAB-DYYB (1,837) INFLIXIMAB (1,231) SECUKINUMAB (1,097) RISANKIZUMAB-RZAA (1,089) CARBIDOPA\LEVODOPA (1,027) ONABOTULINUMTOXINA (907) ERENUMAB-AOOE (805) CERTOLIZUMAB PEGOL (687)

Which CX-024414 Alternatives Have Lower Therapeutic response shortened Risk?

CX-024414 vs CYAMEMAZINE CX-024414 vs CYANOCOBALAMIN CX-024414 vs CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE\RIBOFLAVIN 5'-PHOSPHATE\THIAMINE\VITAMIN B COMPLEX CX-024414 vs CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE\RIBOFLAVIN 5^-PHOSPHATE\THIAMINE\VITAMIN B COMPLEX CX-024414 vs CYANOCOBALAMIN\PYRIDOXINE\THIAMINE

Related Pages

CX-024414 Full Profile All Therapeutic response shortened Reports All Drugs Causing Therapeutic response shortened CX-024414 Demographics